The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
Open accessAbstract
Purpose: Breast cancer arising in young women is correlated with inferior survival and higher incidence of negative clinicopathologic features. The biology driving this aggressive disease has yet to be defined. Patients and Methods: Clinically annotated, microarray data from 784 early-stage breast cancers were identified, and prospectively defined, age-specific cohorts (young: ≤ 45 years, n = 200; older: ≥ 65 years, n = 211) were compared by prognosis, clinicopathologic variables, mRNA expression values, single-gene analysis, and gene set enrichment analysis (GSEA). Univariate and multivariate analyses were performed. Results: Using clinicopathologic variables, young women illustrated lower estrogen receptor (ER) positivity (immunohistochemistry [IHC], P = .027), larger tumors (P = .012), higher human epidermal growth factor receptor 2 (HER-2) overexpression (IHC, P = .075), lymph node positivity (P = .008), higher grade tumors (P < .0001), and trends toward inferior disease-free survival (DFS; hazard ratio = 1.32; P = .094). Using genomic expression analysis, tumors arising in young women had significantly lower ERα mRNA (P < .0001), ERβ (P = .02), and progesterone receptor (PR) expression (P < .0001), but higher HER-2 (P < .0001) and epidermal growth factor receptor (EGFR) expression (P < .0001). Exploratory analysis (GSEA) revealed 367 biologically relevant gene sets significantly distinguishing breast tumors arising in young women. Combining clinicopathologic and genomic variables among tumors arising in young women demonstrated that younger age and lower ERβ and higher EGFR mRNA expression were significant predictors of inferior DFS. Conclusion: This large-scale genomic analysis illustrates that breast cancer arising in young women is a unique biologic entity driven by unifying oncogenic signaling pathways, is characterized by less hormone sensitivity and higher HER-2/EGFR expression, and warrants further study to offer this poor-prognosis group of women better preventative and therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091
Research works printed but not linked: 35
- 10.1056/NEJM198608283150906 · DOI · Paper page
- 10.1186/1471-2407-6-194 · DOI · Paper page
- 10.1200/JCO.1994.12.5.888 · DOI · Paper page
- 10.1016/S0959-8049(97)89017-X · doi:10.1016/s0959-8049(97)89017-x
- 10.1038/bjc.1997.223 · doi:10.1038/bjc.1997.223
- 10.1016/0140-6736(93)92407-K · DOI · Paper page
- 10.1016/S0140-6736(00)02292-3 · DOI · Paper page
- 10.1073/pnas.0409462102 · DOI · Paper page
- 10.1371/journal.pbio.0020007 · DOI · Paper page
- 10.1056/NEJMoa041588 · DOI · Paper page
- 10.1038/35021093 · DOI · Paper page
- 10.1073/pnas.191367098 · DOI · Paper page
- 10.1056/NEJMoa021967 · DOI · Paper page
- 10.1056/NEJMoa052933 · DOI · Paper page
- 10.1038/nature04296 · DOI · Paper page
- 10.1016/S0140-6736(05)70933-8 · doi:10.1016/s0140-6736(05)70933-8
- 10.1158/0008-5472.CAN-05-4414 · DOI · Paper page
- 10.1038/nm1491 · DOI · Paper page
- 10.1056/NEJMcp054015 · DOI
- Harrell FE: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, p 58,2001 · DOI · Paper page
- 10.1016/S1470-2045(07)70042-6 · DOI · Paper page
- Kim C, Tang G, Baehner F, et al: A comparison of estrogen receptor (ER) measurement by three methods in node negative, estrogen receptor (ER) positive breast cancer: Ligand binding (LB), immunohistochemistry (IHC), and quantitative RT-PC. 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 14-17 , 2006 (abstr 3116)
- 10.1200/JCO.2006.10.3754 · DOI · Paper page
- 10.1126/science.3012781 · DOI · Paper page
- Hartley M, McKinley B, Rogers E, et al: Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: A case-control study. Am Surg 72:1189,2006-1194, · DOI
- 10.1023/A:1006498721508 · doi:10.1023/a:1006498721508
- 10.1126/science.2999974 · DOI · Paper page
- 10.1038/modpathol.3800453 · DOI · Paper page
- 10.1093/jnci/djh115 · doi:10.1093/jnci/djh115
- 10.1001/jama.295.21.2492 · DOI · Paper page
- 10.1073/pnas.0932692100 · DOI · Paper page
- 10.1136/jcp.2004.019885 · DOI · Paper page
- 10.1097/00008571-200204000-00012 · doi:10.1097/00008571-200204000-00012
- 10.1001/jama.279.12.922 · DOI · Paper page
- 10.1056/NEJM199601183340301 · DOI · Paper page
Cited by
Gnerlich, J. L., Deshpande, A. D., Jeffe, D. B., Sweet, A., White, N., & Margenthaler, J. A. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2008.12.001 · Cited by 441
Del Mastro, L., Boni, L., Michelotti, A., Gamucci, T., Olmeo, N., Gori, S., Giordano, M., Garrone, O., Pronzato, P., Bighin, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.991 · Cited by 351
Collins, L. C., Marotti, J. D., Gelber, S., Cole, K., Ruddy, K., Kereakoglow, S., Brachtel, E. F., Schapira, L., Come, S. E., Winer, E. P., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1872-9 · Cited by 271
An iron regulatory gene signature predicts outcome in breast cancer
Miller, L. D., Coffman, L. G., Chou, J. W., Black, M. A., Bergh, J., D'Agostino, R., Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1870 · Cited by 202
“It has been reported that breast cancer in younger women represents a unique biological entity, with increased expression of genes related to hypoxia and other signaling pathways (33).”
Age-specific changes in intrinsic breast cancer subtypes: a focus on older women
Jenkins, E. O., Deal, A. M., Anders, C. K., Prat, A., Perou, C. M., Carey, L. A., & Muss, H. B. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0184 · Cited by 165
Self-citation
Metadata
- Authors
- Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., Nevins, J. R., Potti, A., & Blackwell, K. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-07-10
- Volume
- 26
- Issue
- 20
- Pages
- 3324-3330
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2161849165
- Cited by
- 911
- References
- 3
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression. https://app.cochat.ai/papers/10.1200/jco.2007.14.2471
- The paper
- Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., Nevins, J. R., Potti, A., & Blackwell, K. L. (2008). Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2007.14.2471
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
